Human Papillomavirus 11 Recombinant
Human Papillomavirus 16 Recombinant
The Recombinant HPV-16 antigen is a full length protein expressed in E. coli having an Mw of 56.7kDa. The protein is fused to a GST-Tag, having a total Mw of 82.7kDA and purified by standard chromatography.
Human Papillomavirus 18 Recombinant
The Recombinant HPV-18 is a full length large capsid protein having an Mw of 55kDa expressed in E. coli and fused to a GST-Tag at n-terminal, having a total Mw of 78kDa, purified by standard chromatography.
Human Papillomavirus 6 Recombinant
Human Papillomavirus 16 E6 Recombinant
Papillomaviruses (PVs) are a diverse group of DNA viruses belonging to the family Papillomaviridae. They are known to infect the epithelial cells of the skin and mucous membranes in humans and various animals. There are over 200 identified types of human papillomaviruses (HPVs), which are classified into five genera: Alphapapillomavirus, Betapapillomavirus, Gammapapillomavirus, Mupapillomavirus, and Nupapillomavirus . These viruses are further categorized based on their oncogenic potential into high-risk types, which are associated with cancers, and low-risk types, which typically cause benign lesions like warts .
HPVs are small, non-enveloped viruses with a circular double-stranded DNA genome. They exhibit tissue tropism, primarily infecting the basal layer of the stratified epithelium . The viral genome encodes early (E) proteins involved in viral replication and late (L) proteins that form the viral capsid . Expression patterns of HPV genes are tightly regulated and vary depending on the stage of the viral life cycle and the differentiation state of the host cell . HPVs are distributed across various tissues, including the skin, genital tract, and oropharyngeal region .
The primary biological function of HPVs is to infect epithelial cells and replicate within them. High-risk HPVs, such as HPV16 and HPV18, are known to interfere with host cell cycle regulation by expressing oncoproteins E6 and E7, which inactivate tumor suppressor proteins p53 and Rb . This disruption can lead to uncontrolled cell proliferation and, ultimately, cancer . HPVs also play a role in immune evasion by modulating the host’s immune response, allowing persistent infection .
HPVs enter the host through microabrasions in the epithelium and establish infection in the basal cells . The viral E6 and E7 proteins are key players in the virus’s oncogenic mechanisms. E6 promotes the degradation of p53, while E7 binds to and inactivates Rb, leading to cell cycle dysregulation . These interactions trigger downstream signaling cascades that promote cell proliferation and survival, contributing to the development of malignancies .
The expression and activity of HPV genes are regulated at multiple levels. Transcriptional regulation involves the viral upstream regulatory region (URR), which contains promoter and enhancer elements . Post-translational modifications, such as phosphorylation and ubiquitination, also play a role in modulating the stability and function of viral proteins . Additionally, epigenetic mechanisms, including DNA methylation and histone modification, influence viral gene expression and the progression of the viral life cycle .
HPVs have significant applications in biomedical research, particularly in understanding viral oncogenesis and developing preventive and therapeutic strategies. HPV vaccines, such as the quadrivalent and nonavalent vaccines, have been highly effective in preventing infections with high-risk HPV types and reducing the incidence of cervical cancer . Diagnostic tools, including HPV DNA tests and Pap smears, are crucial for early detection and management of HPV-associated diseases . Therapeutic strategies targeting HPV oncoproteins and immune modulation are also being explored .
The HPV life cycle is closely linked to the differentiation of the host epithelial cells . The virus infects basal cells, where it establishes a persistent infection and maintains its genome as an episome . As the infected cells differentiate and move towards the epithelial surface, the virus undergoes genome amplification, late gene expression, and virion assembly . The mature virions are eventually released from the shedding epithelial cells, ready to infect new hosts . Throughout the life cycle, HPVs can evade the host immune response, contributing to persistent infections and the potential for malignant transformation .